首页> 外文期刊>Advanced functional materials >Nanoheterojunction Engineering Enables NIR-Ⅱ-Triggered Photonic Hyperthermia and Pyroelectric Catalysis for Tumor-Synergistic Therapy
【24h】

Nanoheterojunction Engineering Enables NIR-Ⅱ-Triggered Photonic Hyperthermia and Pyroelectric Catalysis for Tumor-Synergistic Therapy

机译:Nanoheterojunction Engineering Enables NIR-Ⅱ-Triggered Photonic Hyperthermia and Pyroelectric Catalysis for Tumor-Synergistic Therapy

获取原文
获取原文并翻译 | 示例
           

摘要

Photodynamic therapy (PDT) as a non-invasive strategy shows high promisein cancer treatment. However, owing to the hypoxic tumor microenvironmentand light irradiation-mediated rapid electron–hole pair recombination,the therapeutic efficacy of PDT is dramatically discounted by limited reactiveoxygen species (ROS) generation. Herein, a multifunctional theranosticnanoheterojunction is rationally developed, in which 2D niobium carbide(Nb_2C) Mxene is in situ grown with barium titanate (BTO) to generate arobust photo-pyroelectric catalyst, termed as BTO@Nb2C nanosheets, forenhanced ROS production, originating from the effective electron–holepair separation induced by the pyroelectric effect. Under the second nearinfrared(NIR-Ⅱ) laser irradiation, Nb_2C Mxene core-mediated photonichyperthermia regulates temperature variation around BTO shells facilitatingthe electron–hole spatial separation, which reacts with the surroundingO_2 and H_2O molecules to yield toxic ROS, achieving a synergetic effect bymeans of combinaterial photothermal therapy with pyrocatalytic therapy.Correspondingly, the engineered BTO@Nb2C composite nanosheets featurebenign biocompatibility and high antitumor efficiency with the tumorinhibitionrate of 94.9% in vivo, which can be applied as an imaging-guidedreal-time non-invasive synergetic dual-mode therapeutic nanomedicine forefficient tumor nanotherapy.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号